Pharmicell Co., Ltd. - ROE
005690.KS
Price:
$10660
Market Cap:
$639.64B
Headquartered in Seoul, South Korea, Pharmicell Co., Ltd. is a biopharmaceutical company established in 2002, actively developing and marketing stem cell treatments across South Korea and globally. The firm operates through two primary segments: Biopharmaceutical Business and Biochemical Business. Its flagship approved product, Cellgram_AMI, leverages a patient's own bone marrow-derived mesenchymal stem cells to enhance heart pumping capacity (ejection fraction) in individuals who have suffered acute myocardial infarction and subsequently undergone coronary angioplasty. Beyond this, Pharmicell is actively progressing several pipeline candidates, including Cellgram_LC for liver ailments, Cell...[Read more]
Industry
Biotechnology
IPO Date
2000-01-04
Stock Exchange
KSC
Ticker
005690.KS
PE Ratio
[14.68]
ROE
[36.50%]
Current Ratio
[7.15]
Dividend Yield
[0.47%]
Enterprise Value
[650.13B]
Dividend History
The ROE as of August 2026 (TTM) for Pharmicell Co., Ltd. (005690.KS) is 36.50%
According to Pharmicell Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 36.50%. This represents a change of 297.92% compared to the average of 9.17% of the last 4 quarters.
Pharmicell Co., Ltd. (005690.KS) Historical ROE (quarterly & annually)
How has 005690.KS ROE performed in the past?
The mean historical ROE of Pharmicell Co., Ltd. over the last ten years is -0.99%. The current 36.50% ROE has changed -3786.88% with respect to the historical average. Over the past ten years (40 quarters), 005690.KS's ROE was at its highest in in the December 2025 quarter at 12.68%. The ROE was at its lowest in in the December 2017 quarter at -63.99%.
Average
-0.99%
Median
7.88%
Minimum
-70.00%
Maximum
32.56%
Pharmicell Co., Ltd. (005690.KS) ROE by Quarter and Year
Discovering the peaks and valleys of Pharmicell Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 9.69%
Maximum Annual ROE = 32.56%
Minimum Annual Increase = -131.60%
Minimum Annual ROE = -70.00%
| Year | ROE | Change |
|---|---|---|
| 2025 | 32.56% | 344.48% |
| 2024 | 7.32% | 64.58% |
| 2023 | 4.45% | -58.70% |
| 2022 | 10.78% | -27.17% |
| 2021 | 14.80% | 61.20% |
| 2020 | 9.18% | 8.79% |
| 2019 | 8.44% | -131.60% |
| 2018 | -26.70% | -61.86% |
| 2017 | -70.00% | 9.69% |
| 2016 | -0.72% | -89.77% |
Pharmicell Co., Ltd. (005690.KS) Average ROE
How has 005690.KS ROE performed in the past?
The current ROE of Pharmicell Co., Ltd. (005690.KS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
14.78%
5-year avg
13.98%
10-year avg
-0.99%
Pharmicell Co., Ltd. (005690.KS) ROE vs. Peers
How is 005690.KS’s ROE compared to its peers?
Pharmicell Co., Ltd.’s ROE is less than Onconic Therapeutics (31.68%), greater than GC Corp. (-4.01%), less than Orum Therapeutics, Inc. (62.90%), greater than GC Corp. (-13.42%), less than Medy-Tox Inc. (3.68%), greater than Prestige BioPharma Limited (-22.81%), less than Chabiotech Co.,Ltd. (3.61%), greater than MEDIPOST Co., Ltd. (-8.99%), greater than BINEX Co., Ltd. (-16.37%), greater than Genomictree Inc. (-7.59%),
| Company | ROE | Market cap |
|---|---|---|
| 31.68% | $160.69B | |
| -4.01% | $495.93B | |
| 62.90% | $1.32T | |
| -13.42% | $447.94B | |
| 3.68% | $439.28B | |
| -22.81% | $364.78B | |
| 3.61% | $760.37B | |
| -8.99% | $337.31B | |
| -16.37% | $212.42B | |
| -7.59% | $296.28B |
Build a custom stock screener for Pharmicell Co., Ltd. (005690.KS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmicell Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Pharmicell Co., Ltd. (005690.KS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Pharmicell Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Pharmicell Co., Ltd.'s ROE?
How is the ROE calculated for Pharmicell Co., Ltd. (005690.KS)?
What is the highest ROE for Pharmicell Co., Ltd. (005690.KS)?
What is the 3-year average ROE for Pharmicell Co., Ltd. (005690.KS)?
What is the 5-year average ROE for Pharmicell Co., Ltd. (005690.KS)?
How does the current ROE for Pharmicell Co., Ltd. (005690.KS) compare to its historical average?